521 related articles for article (PubMed ID: 8842450)
21. Species and age-dependent differences of functional coupling between opioid delta-receptor and G-proteins and possible involvement of protein kinase C in striatal membranes.
Fukushima N; Ueda H; Hayashi C; Katayama T; Miyamae T; Misu Y
Neurosci Lett; 1994 Jul; 176(1):55-8. PubMed ID: 7526302
[TBL] [Abstract][Full Text] [Related]
22. [Met]enkephalin in the spinal cord is involved in the antinociception induced by intracerebroventricularly-administered etorphine in the mouse.
Xu JY; Tseng LF
Neuroscience; 1997 Sep; 80(2):579-85. PubMed ID: 9284359
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment with beta-endorphin facilitates the attenuation of delta-opioid receptor-mediated antinociception caused by delta-opioid receptor antisense oligodeoxynucleotide.
Tseng LF; Narita M; Kampine JP
Eur J Pharmacol; 1995 Dec; 287(2):169-72. PubMed ID: 8749031
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
25. Possible mechanisms for insulin-induced attenuation of the antinociceptive effect of [D-Ala2, N-MePhe4, Gly-ol5]enkephalin.
Ohsawa M; Tanaka S; Kamei J
Eur J Pharmacol; 1999 Jun; 373(2-3):181-6. PubMed ID: 10414437
[TBL] [Abstract][Full Text] [Related]
26. Antisense oligodeoxynucleotide to a delta-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered delta-, but not mu-, epsilon- or kappa-opioid receptor agonists in the mouse.
Wang HQ; Kampine JP; Tseng LF
Neuroscience; 1996 Nov; 75(2):445-52. PubMed ID: 8931008
[TBL] [Abstract][Full Text] [Related]
27. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
Bilsky EJ; Bernstein RN; Pasternak GW; Hruby VJ; Patel D; Porreca F; Lai J
Life Sci; 1994; 55(2):PL37-43. PubMed ID: 8015351
[TBL] [Abstract][Full Text] [Related]
28. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
Gouardères C; Jhamandas K; Sutak M; Zajac JM
Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
[TBL] [Abstract][Full Text] [Related]
29. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
30. Supraspinal delta 2 opioid agonist analgesia in Swiss-Webster mice involves spinal GABAA receptors.
Rady JJ; Fujimoto JM
Pharmacol Biochem Behav; 1996 Jun; 54(2):363-9. PubMed ID: 8743596
[TBL] [Abstract][Full Text] [Related]
31. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
[TBL] [Abstract][Full Text] [Related]
32. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
33. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
34. Interaction between medullary and spinal delta1 and delta2 opioid receptors in the production of antinociception in the rat.
Hurley RW; Grabow TS; Tallarida RJ; Hammond DL
J Pharmacol Exp Ther; 1999 May; 289(2):993-9. PubMed ID: 10215679
[TBL] [Abstract][Full Text] [Related]
35. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
Horan PJ; Wild KD; Misicka A; Lipkowski A; Haaseth RC; Hruby VJ; Weber SJ; Davis TP; Yamamura HI; Porreca F
J Pharmacol Exp Ther; 1993 May; 265(2):896-902. PubMed ID: 8388462
[TBL] [Abstract][Full Text] [Related]
36. Lack of antinociceptive efficacy of intracerebroventricular [D-Ala2,Glu4]deltorphin, but not [D-Pen2,D-Pen5]enkephalin, in the mu-opioid receptor deficient CXBK mouse.
Raffa RB; Martinez RP; Porreca F
Eur J Pharmacol; 1992 Jun; 216(3):453-6. PubMed ID: 1330585
[TBL] [Abstract][Full Text] [Related]
37. Phorbol ester blocks the increase of a high affinity GTPase activity induced by delta 2-opioid receptor agonist in the mouse spinal cord.
Narita M; Mizoguchi H; Tseng LF
Eur J Pharmacol; 1996 Aug; 310(2-3):R1-3. PubMed ID: 8884228
[TBL] [Abstract][Full Text] [Related]
38. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
39. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
40. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]